A randomised controlled trial of mifepristone followed by misoprostol 6-8hrs versus 23-25hrs for abortion upto 10weeks of gestation.

SDM College of medical sciences and hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Only women with a visible intrauterine gestational sac were enrolled. Mean sac diameter (length width depth/3) was used to determine estimated gestational age (EGA) only when an embryonic pole was absent. Last menstrual period was used to determine EGA if the last menstrual period was within 3 days of the ultrasound EGA; however, the ultrasound estimate was used if it differed by 4 days or more from the EGA by last menstrual period.

•Potential subjects were EXCLUDED if they had any contraindication to mifepristone, including chronic systemic corticosteroid administration or adrenal disease; had any contraindications to misoprostol, including glaucoma, mitral stenosis, sickle cell anemia, poorly controlled seizure disorder, or known allergy to prostaglandin; had cardiovascular disease, including angina, valvular disease, arrhythmia, or cardiac failure; had a known coagulopathy or were receiving treatment with anticoagulants; had a pregnancy with an intrauterine device in utero; had active cervicitis on examination; if their ultrasound examination results demonstrated any evidence of an early pregnancy failure, had previously participated in the trial.

发起方